MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Profiling Neural Protein Dopaminylation in Parkinson’s disease

    W. Chen, I. Maze (NEW YORK, USA)

    Objective: The hallmark of Parkinson’s Disease is motor dysfunction from the decline in dopaminergic cells in the substantia nigra (SN), leading to the development of…
  • 2025 International Congress

    Effect of Aβ on α-synuclein propagation

    Y. Narumiya, E. Nakanishi, T. Taguchi, M. Sawamura, N. Uemura, T. Maki, T. Saito, R. Takahashi, R. Matsumoto, H. Yamakado (Nagoya, Japan)

    Objective: To investigate how amyloid-beta (Aβ) pathology affects α-synuclein (α-syn) propagation. Background: Lewy bodies, the pathological hallmark of Parkinson’s disease and dementia with Lewy bodies,…
  • 2025 International Congress

    Prevalence and Clinical Characteristics of iNPH-Related Imaging Findings (DESH) in Parkinson’s Disease

    T. Baba, T. Totsune, T. Nakamura, Y. Sugimura, H. Oizumi, H. Tanaka, T. Takahashi, M. Yoshioka, K. Nagamatsu, T. Hasegawa, A. Takeda (Sendai, Japan)

    Objective: To investigate the prevalence of idiopathic normal pressure hydrocephalus (iNPH)-related imaging findings (DESH) and their clinical characteristics in Parkinson’s disease (PD) patients. Background: PD…
  • 2025 International Congress

    MultiModal Transformer-Based Detection of Parkinson’s Disease in fMRI Extracted Time Series

    S. Patel, C. Antoniades, J. Fitzgerald, O. Bredemeyer (Oxford, United Kingdom)

    Objective: Develop and evaluate a multimodal, transformer-based pipeline for detecting Parkinson’s disease (PD) from resting-state fMRI time series, aiming to expose short-lived neural connectivity disruptions…
  • 2025 International Congress

    Brain hemodynamic responses to a motor control paradigm in younger and older adults, and people with Parkinson’s Disease: An fNIRS mediated feasibility study.

    M. Bjalme-Evans, K. Heffernan, D. Wani, S. Leung, J. Carter, A. Bowden, A. Raghunathan, L. Quinn (New York, USA)

    Objective: This study aims to investigate the use of fNIRS in measuring the hemodynamic response of the brain during motor control tasks of increasing complexity…
  • 2025 International Congress

    First in Class ASO Targeting A53T Allele: Preclinical Efficacy

    S. Smieszek, B. Przychodzen, C. Tyner, C. Polymeropoulos, G. Birznieks, M. Polymeropoulos (Washington, USA)

    Objective: Our objective was to develop an antisense oligonucleotide (ASO) allele-specific strategy to target the mutant A53T SNCA allele, reducing aberrant α-synuclein production, without downregulating…
  • 2025 International Congress

    Rapid Neurologic Decline after Subthalamic Nucleus Deep Brain Stimulation in Leucine-Rich Repeat Kinase 2 Parkinson’s disease (LRRK2-PD)

    T. Haddad, M. Rochman, TW. Liang (Phialdelphia, USA)

    Objective: To describe the clinical outcomes of two unrelated patients with LRRK2-PD who experienced rapid neurologic decline following subthalamic nucleus deep brain stimulation (STN-DBS). Background:…
  • 2025 International Congress

    Genetic Analysis of Parkinson’s Disease in Crete

    I. Boura, S. Sait, N. Marinakis, A. Kumar, P. Reho, I. Vatsellas, T. Loupis, P. Makrythanasis, P. Mitsias, G. Xiromerisiou, S. Scholz, C. Spanaki (Heraklion, Crete, Greece)

    Objective: We aimed to investigate the genetic architecture of Parkinson’s disease (PD) in the island-based Cretan population by identifying pathogenic/likely pathogenic variants (ACMG criteria), in…
  • 2025 International Congress

    Insights into Ancestral Diversity in Parkinson’s Disease Risk: A Comparative Assessment of Polygenic Risk Scores

    S. Grant, P. Saffie-Awad, M. Makarious, I. Elsayed, A. Sanyaolu, P. Wild Crea, A. Schumacher Schuh, K. Levine, D. Vitale, M. Koretsky, J. Kim, T. Leal, M. Periñan, S. Dey, A. Noyce, A. Reyes-Palomares, N. Rodriguez-Losada, J. Foo, W. Mohamed, K. Heilbron, L. Norcliffe-Kaufmann, M. Rizig, N. Okubadejo, M. Nalls, C. Blauwendraat, A. Singleton, H. Leonard, I. Mata, S. Bandres-Ciga (Bethesda, USA)

    Objective: This study aims to provide a comprehensive assessment of PRS performance across ancestries and highlight the limitations of a “one-size-fits-all” approach to genetic risk…
  • 2025 International Congress

    Large-scale genetic characterization of Parkinson’s disease in the African and African admixed populations

    F. Akcimen (Bethesda, USA)

    Objective: The influence of genetics has been primarily studied in European populations, limiting our understanding of the genetic landscape of PD in the African and…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley